The FDA has given the green light to Moderna’s mRNA-based respiratory syncytial virus vaccine, specifically for older adults, the drugmaker announced May 31.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
FDA approves Moderna's RSV shot for older adults
